首页> 外国专利> Pharmaceutical composition, injectable solution and vial comprising parecoxib or salt thereof and process for preparing reconstitutable selective COX-2 inhibitory composition

Pharmaceutical composition, injectable solution and vial comprising parecoxib or salt thereof and process for preparing reconstitutable selective COX-2 inhibitory composition

机译:包含帕瑞昔布或其盐的药物组合物,注射溶液和小瓶以及制备可重构的选择性COX-2抑制组合物的方法

摘要

The pharmaceutical composition comprising, in powder form, (a) parecoxib or salt thereof in a therapeutically effective total amount constituting 30 % to 90 % by weight of the composition; (b) parenterally acceptable buffering agent in an amount 10 % to 60 % by weight of the composition; (c) optionally other parenterally acceptable excipient ingredients in a total amount of up to 10 % by weight of the composition, said composition being reconstitutable in a parenterally acceptable solvent liquid to form an injectable solution. Disclosed are also process for preparing the composition by lyophilisation, an injectable solution prepared by reconstituting the composition and a sealed vial containing a unit dosage amount of the composition.
机译:该药物组合物包含粉末形式的(a)治疗有效总量的帕瑞昔布或其盐,其占该组合物重量的30%至90%;和(b)肠胃外可接受的缓冲剂,其用量为组合物重量的10%至60%; (c)任选地总量不超过组合物重量的10%的其他肠胃外可接受的赋形剂成分,所述组合物可在肠胃外可接受的溶剂液体中重构以形成可注射溶液。还公开了通过冻干制备组合物的方法,通过重构组合物制备的可注射溶液和包含单位剂量的组合物的密封小瓶。

著录项

  • 公开/公告号SK287754B6

    专利类型

  • 公开/公告日2011-08-04

    原文格式PDF

  • 申请/专利权人 PHARMACIA CORPORATION;

    申请/专利号SK20030001228

  • 发明设计人 KARARLI TUGRUL T.;NEMA SANDEEP;KARIM AZIZ;

    申请日2002-04-02

  • 分类号A61K31/42;C07D237/16;A61K9;A61K9/08;A61K9/19;A61K31;A61K31/122;A61K31/352;A61K31/365;A61K31/415;A61K31/444;A61K31/50;A61K45/08;A61K47/02;A61K47/04;A61K47/12;A61K47/18;A61K47/36;A61P29;A61P29;C07D213/61;C07D231/12;C07D261/08;C07D307/58;C07D311/58;

  • 国家 SK

  • 入库时间 2022-08-21 18:04:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号